Zurn Elkay Water Stock Market Outlook

ZWS Stock  USD 51.19  0.14  0.27%   
Zurn Elkay's news sentiment is one input in the broader outlook framework for the stock and is intended to describe tone, not investor suitability. About 56% of recent sentiment around Zurn Elkay has been slightly more constructive than defensive over the recent sample. Taken on its own, that leaves the current sentiment reading for Zurn Elkay Water slightly above neutral currently.
Investor Comfort Level
PanicConfidence
56 · Interested

Elasticity to Hype and News Sentiment

Tracking Zurn Elkay Water positive news sentiment (74%) is particularly informative when headlines and price behavior start diverging. Whether that tone sustains depends on how the next batch of company disclosures compares with the current media narrative.
Over a 90-day investment horizon, with an above-average risk tolerance, the model output for Zurn Elkay Water is 'Strong Hold'. The buy or sell recommendation for Zurn Elkay is an algorithmically generated signal based on multiple inputs. The analysis factors in the investor's historical horizon and risk tolerance parameters. Historical patterns and current fundamentals for Zurn Elkay are both incorporated into the output.
  

Run Zurn Elkay Outlook Model

The Zurn Elkay outlook provides an algorithm-driven perspective alongside analyst coverage of Zurn Elkay Water. Macroaxis does not own or hold any residual interests in Zurn Elkay Water or other covered equities. The Zurn Elkay's signal adjusts as new market data becomes available.

How This Model Works

The recommendation output for Zurn Elkay is a model-based view that converts the selected horizon and risk profile into a standardized reading of the current evidence.

  • Inputs - valuation signals, price behavior, volatility, liquidity, sentiment, and analyst coverage when available
  • Current setup - Three Months with a risk setting described as I am an educated risk taker
  • Limits - the model does not account for taxes, outside holdings, concentration constraints, or investor-specific mandates

Use the output as structured decision support and pair it with your own research, portfolio context, and any professional advice you rely on.

Time Horizon

Risk Tolerance

Update Outlook
SellBuy
Strong Hold

Market Performance

WeakDetails

Volatility

Very LowDetails

Current Valuation

Aligned With ModelDetails

Odds Of Distress

MinimalDetails

Economic Sensitivity

Responds to the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
Zurn Elkay's current outlook reflects mixed signals, where recent market performance has undercut momentum, while contained volatility and intact fundamental quality provide partial offset. The model's 'Strong Hold' signal reflects this balance across quantitative inputs rather than a directional bias. A Strong Hold typically corresponds to a setup where valuation and volatility metrics limit downside pressure, but the absence of clear catalysts constrains upside visibility. Key risk-adjusted readings for Zurn Elkay include Risk Adjusted Performance of 0.008, Jensen Alpha of -0.0013, and Total Risk Alpha of 2.0E-4, which frame a constrained risk-reward profile.
Zurn Elkay's analytical framework reflects a quantitative assessment of growth potential, downside exposure, and market positioning relative to the analyst consensus. For additional context on this mid-cap stock in the Industrials sector, consider the full set of Zurn Elkay reported fundamentals, including total debt ttm, book value per share ttm, and the relationship between the net income ttm and earnings per share. At a price to earnings ttm of 12.48 X, Zurn Elkay's broader market performance and downside risk provide additional analytical context.

Recent Events and Market Context

The events below reflect recent headlines associated with Zurn Elkay. Not all items directly affect the outlook โ€” they are included to show the broader information environment that can shape sentiment and trading behavior.

Returns Distribution Density

This graph charts the range of Zurn Elkay's past daily returns for Zurn Elkay. Most returns cluster near the average, but the tails show how often large gains or losses occur. Value At Risk and Upside Potential mark the key boundaries of Zurn Elkay's return range.
Mean Return
0.01
Value At Risk
-2.45
Potential Upside
3.27
Standard Deviation
2.02
   Return Density   
       Distribution  
Risk management for Zurn Elkay comes down to one question: how likely are sharp price moves? The chart of Zurn Elkay's past returns makes it easy to see how often extreme moves have happened. It is a practical tool for comparing the risk-reward balance of different risk-return profiles.

Top Institutional Investors

At mid-cap scale, institutional coverage and secondary-market liquidity are typically well established. The holder split in Zurn Elkay Water separates passive index allocation from active institutional positioning. Shares outstanding are near 166.87 million. Whether the institutional base is growing or shrinking quarter over quarter matters more than the current snapshot.
Shares
First Trust Advisors L.p.2025-12-31
3.3 M
Delaware Management Holdings Inc2025-12-31
3.2 M
Impax Asset Management Group Plc2025-12-31
2.9 M
T. Rowe Price Associates, Inc.2025-12-31
2.7 M
Dimensional Fund Advisors, Inc.2026-03-31
2.6 M
Norges Bank2025-12-31
2.4 M
Crescent Grove Advisors, Llc2025-12-31
2.3 M
Wells Fargo & Co2025-12-31
2.3 M
Charles Schwab Investment Management Inc2025-12-31
2.1 M
Blackrock Inc2025-12-31
23.7 M
Vanguard Group Inc2025-12-31
16.7 M
Zurn Elkay Water mid-cap profile at 8.58 billion shapes market structure and potential liquidity pressure during stressed periods. Annual revenue is about 1.7 billion. At this size, institutional entries and exits have a more visible impact on daily volume.

Cash Flow Accounts

20222023202420252026 (projected)
Other Cashflows From Investing Activities1M16.7M1.6M-29.9M-28.4M

Key Drivers of Volatility and Market Exposure

Zurn Elkay reflects a blend of market-wide risk and company or sector-specific developments. Historical volatility and beta quantify how it responds to broader cycles. Zurn Elkay Water's financial profile includes a Downside Deviation of 1.58, a Mean Deviation of 1.30, and a Semi Deviation of 1.55.
α
Alpha over Dow Jones
-0.0013
β
Beta against Dow Jones1.40
σ
Overall volatility
2.00
Ir
Information ratio -0.0011
Zurn Elkay Water volatility analysis combines downside deviation and total dispersion to frame price movement. Zurn Elkay Water beta reading of 1.4041 points to above-average exposure to systematic risk. A Sharpe ratio of 0.0032 helps contextualize whether Zurn Elkay Water recent volatility has been accompanied by proportional returns.

Fundamentals Vs Peers

Benchmarking Zurn Elkay's key metrics against industry peers converts raw numbers into relative positioning. The comparison exposes whether Zurn Elkay is trading at a premium or discount to its peer group on key ratios. Persistent fundamental advantages at Zurn Elkay relative to peers often correlate with sustained valuation premiums.
    
 Better Than Average     
    
 Worse Than Average Compare Zurn Elkay to competition
FundamentalsZurn ElkayPeer Average
Return On Equity TTM0.13-0.31
Return On Asset TTM0.072-0.14
Profit Margin TTM0.12-1.27
Operating Margin TTM0.19-5.51
Current Valuation8.82 B16.62 billion
Shares Outstanding166.87 M571.82 million
Shares Owned By Insiders11.79 %10.09 %
Shares Owned By Institutions97.45 %39.21 %
Number Of Shares Shorted5.31 M4.71 million
Price To Earnings TTM12.48 X28.72 X
Price To Book TTM5.32 X9.51 X
Price To Sales TTM4.93 X11.42 X
Revenue TTM1.7 B9.43 billion
Gross Profit TTM789.6 M27.38 billion
EBITDA TTM373.6 M3.9 billion
Net Income TTM198 M570.98 million
Cash And Equivalents TTM300.5 M2.7 billion
Cash Per Share TTM0.40 X5.01 X
Total Debt TTM580.5 M5.32 billion
Debt To Equity TTM0.37 %48.70 %
Current Ratio TTM2.43 X2.16 X
Book Value Per Share TTM9.62 X1,931
Cash Flow From Operations TTM346.5 M971.22 million
Short Ratio TTM5.61 X4.00 X
Earnings Per Share1.23 X3.12 X
Price To Earnings To Growth1.80 X4.89 X
Target Price56.22N/A
Number Of Employees2.6 K18,840
Trailing Beta0.86-0.15
Market Capitalization TTM8.58 B19.03 billion
Total Asset TTM2.68 B29.47 billion
Retained Earnings TTM-1.13 B9.33 billion
Working Capital TTM552.3 M1.48 billion
Note: Acquisition by Michael Troutman of 7253 shares of Zurn Elkay at 33.05 subject to Rule 16 b-3 [view details]

Market Momentum

Zurn Elkay Water momentum reading - RSI 54 (neutral), beta 1.4041 (above-market-beta) - helps distinguish trend continuation from fading conviction. Comparing these readings with sector peers helps separate stock-specific momentum from amplified market moves.

Current Target Price Consensus

To arrive at Zurn Elkay's target price, all analyst estimates are collected and averaged. Measuring analyst accuracy is challenging and typically requires detailed attribution analysis against historical results. Zurn Elkay's target price projections are most actionable when paired with earnings analysis and sentiment measures.
   8  Buy
Zurn Elkay is reviewed by analysts roughly four times per year with each update including a target price. Each rating is paired with a target price comparing Zurn Elkay Water's intrinsic value estimate against its market price. Analysts base their judgments on Zurn Elkay Water's public disclosures, management interactions, and broader market research.
Exposure   Valuation

Zurn Elkay Target Price Projection

The current trading price of Zurn Elkay is 51.19, compared to an average analyst target of 56.22. The current price of Zurn Elkay is what Zurn Elkay Water trades for on the market, while the target reflects analyst intrinsic value estimates. The magnitude of the gap between these prices is often a key driver of investor behavior.

Current Price

Zurn Elkay Market Quote on 11th of May 2026

Low Price50.71Odds
High Price51.59Odds

51.19

Target Price

Analyst Consensus On Zurn Elkay Target Price

Low Estimate51.16Odds
High Estimate62.41Odds

56.22

Historical Lowest Forecast  51.16 Target Price  56.22 Highest Forecast  62.41
Analysts typically disclose Zurn Elkay's price targets within comprehensive research notes. Although price targets are often quoted in financial news media, there could be a delay in updating the data shown here. The price targets displayed for Zurn Elkay Water originate from analyst research notes with investment recommendations.

Zurn Elkay Analyst Ratings

Zurn Elkay is rated Buy by 8 analysts who actively follow the stock. 3 rate it a Buy or Strong Buy, while 0 rate it negatively. The net tone among covering analysts is leaning bullish at this time.

Analyst Consensus Breakdown

Average Consensus Estimates

Recommendation Framework, Assumptions & Editorial Oversight

The model output for Zurn Elkay reflects the current horizon and risk settings, refreshes as underlying data changes, and is intended to organize evidence rather than replace investor judgment. Current model inputs for Zurn Elkay include P/E of 12.48, ROE of 13.33%. External analyst coverage is currently summarized as Buy across 8 analysts, but it is treated here as a secondary reference input rather than a stand-alone recommendation. Published target-price assumptions may also be reviewed when available, but they can change quickly as analyst models are revised.

Zurn Elkay Water inputs come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. The model combines valuation, price behavior, volatility, and sentiment into a standardized quantitative view.

Editorial Review & Methodology Oversight

Ellen Johnson
Role: Member of Macroaxis Editorial Board
Finance background: Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
Oversight scope: Reviews recommendation-framework framing, source assumptions, and disclosure language.
Last reviewed on April 21st, 2026